Diasol Inc.
Phoenix, AZ Doing business as Discount Medical Supply Diasol Inc.
- UEI
- KHK6KV388KF5
- CAGE
- 67L88
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 310 S 43rd Ave Ste B, Phoenix, AZ 85009, USA
- Website
- diasol.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| FY26 B6 diasol acid-bicarb SEP 26 | Medical Center for Federal Prisoners Springfield | $5,877 | |
| FY26 B6 diasol acid-bicarb AUG 26 | Medical Center for Federal Prisoners Springfield | $19,567 | |
| FY26 B6 diasol acid-bicarb JUL 26 | Medical Center for Federal Prisoners Springfield | $19,567 | |
| FY26 B6 diasol acid-bicarb may 26 | Medical Center for Federal Prisoners Springfield | $18,429 | |
| FY26 B6 diasol acid-bicarb APR 26 | Medical Center for Federal Prisoners Springfield | $18,036 |
About Diasol Inc.
Diasol Inc., doing business as Discount Medical Supply, is a woman-owned small business based in Phoenix, Arizona, that manufactures and supplies specialized hemodialysis consumables—acid concentrates in 2K+ and 3K+ formulations and bicarbonate mixture bags—to the federal correctional healthcare system as a prime contractor. The vendor competes exclusively on full-and-open (non-set-aside) delivery orders, despite its woman-owned small business designation and the fact that its underlying indefinite delivery contracts were originally solicited as total small business set-asides.
Diasol operates as a Subchapter S for-profit corporation under NAICS 325412 (Pharmaceutical Preparation Manufacturing), with 100 percent of recent awards issued as prime contracts carrying no subcontracting relationships. The vendor's federal footprint is highly concentrated: 124 of 130 total awards (95 percent by count, 100 percent by combined potential value of $4.7 million) flow from a single customer, the Department of Justice Bureau of Prisons Medical Center for Federal Prisoners Springfield in Missouri. The remaining six awards are scattered across two Department of Veterans Affairs Veterans Health Administration network sites (Veterans Integrated Service Network 1 and Network 4), combined representing under 1 percent of potential value. This concentration is the dominant signal in Diasol's competitive profile—the vendor is essentially a single-customer specialized supplier to the federal correctional healthcare system.
Diasol operates under two principal indefinite delivery contracts issued by BOP Medical Center for Federal Prisoners Springfield. The predecessor IDC (contract number DJBP041400000065), awarded April 1, 2020, with a $907 thousand ceiling and ultimate completion date of March 31, 2025, generated 59 task orders (combined potential value $700 thousand) through fiscal year 2025. Diasol was succeeded by a new single-award IDC (contract number not named in source) awarded June 1, 2025, valued at $1,336,393.00 and running through May 31, 2031, which has already generated six delivery orders ranging from $15,334.80 to $24,184.48 (combined potential value reaching into six figures based on trajectory). A third BOP IDC (contract number 15BFA025D00000023) has generated 11 task orders valued at $188 thousand. Diasol also holds a VA BOP contract (15B41420D00000063) with 50 task orders valued at $660 thousand. All work is performed in Phoenix, Arizona, with products delivered to support hemodialysis operations at the Springfield facility.
Awards show flat to declining trajectory over the past five years—eight awards in 2022 through six awards in 2026—reflecting the cyclical nature of recurring monthly and quarterly delivery orders rather than new customer acquisition. Activity is driven entirely by standing orders under the two active BOP IDCs. Only two awards (combined potential value $33 thousand) face completion within the next twenty-four months, indicating minimal recompete exposure in the near term; the June 2025 IDC with a $1.336 million ceiling carries the vendor through May 2031. Diasol has maintained this federal prison customer since at least April 2020 and has demonstrated reliable supply of these specialized dialysis consumables, with orders typically issued monthly or quarterly in the $11,000 to $25,000 range. The vendor holds no federal contract vehicles, GWACs, BPAs, or parent IDVs beyond the BOP and VA-based indefinite delivery contracts named above, and carries zero subcontract relationships across its federal footprint.
SBA capabilities narrative
Dialysis solutions, Hemodialysis acid concentrate, Sodium bicarbonate, Dialysis chairs, dialysis supplies, medical recliners.
Quick answers
What is Diasol Inc.'s UEI?
Diasol Inc.'s Unique Entity ID (UEI) in SAM.gov is KHK6KV388KF5.
What is Diasol Inc.'s CAGE code?
Diasol Inc.'s CAGE code is 67L88.
What is Diasol Inc.'s primary NAICS code?
Diasol Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Diasol Inc. located?
Diasol Inc.'s physical address in SAM.gov is 310 S 43rd Ave Ste B, Phoenix, AZ 85009, USA.
Is Diasol Inc. registered in SAM.gov?
Yes. Diasol Inc.'s SAM.gov registration is active through September 22, 2027.
What is Diasol Inc.'s most recent federal award?
Diasol Inc.'s most recent federal contract award is FY26 B6 diasol acid-bicarb SEP 26 (15B41426F00000293), from Medical Center for Federal Prisoners Springfield, on September 30, 2026.
On GovTribe
See Diasol Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors